Cargando…
ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma
Adenoid cystic carcinoma (ACC) is a rare cancer that preferentially occurs in the head and neck, breast, as well as in other sites. It is an aggressive cancer with high rates of recurrence and distant metastasis. Patients with advanced disease are generally incurable due to the lack of effective sys...
Autores principales: | Andersson, Mattias K., Mangiapane, Giovanna, Nevado, Paloma Tejera, Tsakaneli, Alexia, Carlsson, Therese, Corda, Gabriele, Nieddu, Valentina, Abrahamian, Carla, Chayka, Olesya, Rai, Lilam, Wick, Michael, Kedaigle, Amanda, Stenman, Göran, Sala, Arturo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992744/ https://www.ncbi.nlm.nih.gov/pubmed/32001675 http://dx.doi.org/10.1038/s41389-020-0194-3 |
Ejemplares similares
-
Synthetic oleanane triterpenoids suppress MYB oncogene activity and sensitize T-cell acute lymphoblastic leukemia cells to chemotherapy
por: Tejera Nevado, Paloma, et al.
Publicado: (2023) -
Genomic imbalances and MYB fusion in synchronous bilateral adenoid cystic carcinoma and invasive lobular carcinoma of the breast
por: Kovács, Anikó, et al.
Publicado: (2017) -
Addiction of MYCN Amplified Tumours to B-MYB Underscores a Reciprocal Regulatory Loop
por: Gualdrini, Francesco, et al.
Publicado: (2010) -
IGF2/IGF1R Signaling as a Therapeutic Target in MYB-Positive Adenoid Cystic Carcinomas and Other Fusion Gene-Driven Tumors
por: Andersson, Mattias K., et al.
Publicado: (2019) -
Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional Study
por: Persson, Marta, et al.
Publicado: (2022)